Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Voluntary Internet-Based Device Trial Clearinghouse Suggested By MDMA

This article was originally published in The Gray Sheet

Executive Summary

Public access via the Internet to device trial information submitted voluntarily by manufacturers is adequate to direct potential subjects to clinical studies, industry reps maintain.

You may also be interested in...



Medical Journals To Require Registration Of Devices On ClinicalTrials.Gov

Medical device firms as well as pharmaceutical companies will be required to register their clinical trials in a public registry as a prerequisite of journal publication, according to New England Journal of Medicine Executive Editor Gregory Curfman, MD

Medical Journals To Require Registration Of Devices On ClinicalTrials.Gov

Medical device firms as well as pharmaceutical companies will be required to register their clinical trials in a public registry as a prerequisite of journal publication, according to New England Journal of Medicine Executive Editor Gregory Curfman, MD

HHS Suggests Congress Delay Device Trials Registry Decision Until 2001

Congress should delay action on creating a device trials registry until the year 2001, "after there is one year of experience with data from privately funded trials in the drug trials registry," Secretary of Health and Human Services Donna Shalala concludes in a report on the need for and impact of a device clinical trials databank.

Related Content

UsernamePublicRestriction

Register

OM003971

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel